Genmab | GEN - EPS Earnings Per Share


Genmab reported DKK3.69 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Change Date
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
argenx SE USD 4.7 2.1 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Demant DKK 6.1 0.5 Dec/2025
Exelixis USD 0.87 0.1 Mar/2026
Fresenius Medical Care EUR 0.91 0.53 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GN Store Nord DKK -2.65 5.16 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025